Renuglaze Cream is primarily utilised for managing melasma, a skin condition characterised by dark, discoloured facial patches. This medicine is classified under topical skin-lightening agents, formulated to reduce hyperpigmentation and discolouration.
Renuglaze Cream is generally utilised for the following indications:
• Lightening dark patches on the skin due to melasma
• Reducing inflammation associated with skin conditions
• Promoting skin renewal and improving texture
• Diminishing fine wrinkles on the face
• Ensure your face is clean and dry before application.
• Apply the product as directed to the affected areas.
• Wash your hands thoroughly before and after use.
• Apply sunscreen with SPF 30 or higher in the morning and reapply every 2 hours.
Renuglaze Cream is applied topically.
The following side effects may be noticed on using Renuglaze Cream:
• Burning
• Stinging
• Redness
• Dryness
• Peeling
Renuglaze Cream comprises three active components:
• Hydroquinone (2% w/w): Functions by inhibiting tyrosinase, an enzyme essential for melanin synthesis, thus reducing pigmentation.
• Mometasone (0.1% w/w): A medium-potency corticosteroid that mitigates inflammation by inducing lipocortins, which regulate inflammation.
• Tretinoin (0.025% w/w): A retinoid that enhances epidermal cell turnover, promoting the shedding of pigmented cells for improved skin texture.
Renuglaze Cream is advised against use during pregnancy.
Use with caution while breastfeeding.
Apply with caution in cases of liver disease.
Consult your doctor if you have kidney concerns before using this cream.
This cream generally does not affect the ability to drive or operate machinery. Consult your doctor if you experience any side effects that may impair these activities.
Avoid using if allergic to any component of this cream. Discuss any known allergies with your doctor.
Use with caution in children due to a higher risk of skin irritation. Always consult your doctor before use in children.
Use under medical supervision, as older patients may be more susceptible to skin reactions.
Drug-Drug Interactions
• Neuromuscular Blocking Agents: May enhance effects when used concurrently.
• Corticosteroids: Risk of hypothalamic-pituitary-adrenal (HPA) axis suppression when used with other corticosteroids.
• Anticoagulants and NSAIDs: Tretinoin may amplify effects, increasing bleeding risk.
Drug-Disease Interactions
• Hypothalamic-Pituitary-Adrenal Axis Suppression: Systemic absorption of corticosteroids may exacerbate the condition.
• Eczema or Skin Infections: Increased absorption and potential side effects when applied to affected skin.
Daily Dosage
• Apply the cream as prescribed by your doctor. Do not exceed the recommended dosage.
Missed Dose
• If you forget to apply the cream at the scheduled time, apply it as soon as you remember. If it is almost time for your next application, skip the missed dose. Do not double the application.
Overdose
• Overapplication may lead to skin irritation, such as redness, itching, or burning. Consult your doctor if symptoms persist.
• Store Renuglaze Cream at room temperature (20°C to 25°C).
• Keep in a dry place, away from direct sunlight and heat.
• Ensure the tube is tightly closed when not in use.
• Keep out of reach of children.
• Use before the expiry date on the tube.
• Apply sunscreen with SPF 30 or higher when outdoors.
• Avoid using harsh soaps or skin products. Opt for mild cleansers.
• Incorporate a diet rich in antioxidants with brightly coloured fruits and vegetables.
.avif)
%20(1).png)
.webp)